Imiquimod: an old molecule with potentialities against COVID-19

Authors

Keywords:

COVID-19, ADJUVANTS, IMMUNOLOGIC

Abstract

Full text (en español)

Downloads

Download data is not yet available.

Author Biography

Alberto José Piamo-Morales, Hospital General “Dr. José Gregorio Hernández”. Servicio de Anatomía Patológica. Puerto Ayacucho.

Especialista en Anatomía Patológica

References

Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med [revista en internet]. 2020 [citado 25 de abril 2020]; 46:586–90. Disponible en: https://doi.org/10.1007/s00134-020-05985-9.

de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol [revista en internet]. 2016 [citado 25 de abril 2020]; 14:523-34. Disponible en: https://doi.org/10.1038/nrmicro.2016.81.

Patchett AL, Darby JM, Tovar C, Lyons AB, Woods GM. The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines. PLoS One [revista en internet]. 2016 [citado 25 de abril 2020]; 11(12): e0168068. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148113/.

Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clinical and Experimental Dermatology [revista en internet]. 2002 [citado 25 de abril 2020]; 27(7): 571–577. Disponible en: https://doi.org/10.1046/j.1365-2230.2002.01151.

Yuan J, Ni G, Wang T, Mounsey K, Cavezza S, Pan X, et al. Genital warts treatment: Beyond imiquimod. Human Vaccines & Immunotherapeutics [revista en internet]. 2018 [citado 26 de abril 2020]; 14(7): 1815‐1819. Disponible en: https://doi.org/10.1080/21645515.2018.1445947.

Miao X, Luo D, Min W, Lin X, Wang D, Xu Y, et al. Potential efficacy of imiquimod on immunity-related cytokines in murine skin in vivo and in human Langerhans cells in vitro. International Journal of Dermatology [revista en internet]. 2012 [citado 27 de abril 2020]; 51(9): 1116-1122. Disponible en: https://doi.org/10.1111/j.1365-4632.2011.05382.x.

Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol [revista en internet]. 2002 [citado 27 de abril 2020]; 3: 196–200. Disponible en: https://doi.org/10.1038/ni758.

Downloads

Published

2020-05-05

How to Cite

1.
Piamo-Morales AJ. Imiquimod: an old molecule with potentialities against COVID-19. Rev. electron. Zoilo [Internet]. 2020 May 5 [cited 2025 Nov. 18];45(3). Available from: https://revzoilomarinello.sld.cu/index.php/zmv/article/view/2261

Issue

Vol. 45 No. 3 (2020): May-June

Section

Letters to the editor

License

This journal provides free and immediate access to its content under the principle that making research freely available to the public supports a greater exchange of global knowledge. This means that the authors transfer the copyright to the journal, so that copies and distribution of the contents can be made by any means, as long as the authors' acknowledgment is maintained. These terms are a reflection that the journal assumes copyright under Creative Commons licenses, specifically under a Creative Commons Attribution 4.0 International license.

Registration and submission of articles to the journal is free. The processing, including review, editing and publication, is completely free of charge.